Related Experiment Video
Updated: Aug 2, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax
C A Pise-Masison1, R Mahieux, M Radonovich
1Basic Research Laboratory, Virus Tumor Biology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract:
The p53 protein plays a pivotal role in transmitting signals from many forms of genotoxic stress to genes and factors that control aspects of the cell cycle and death. Although mutated in approximately 60% of all human cancers, only a minority of human T-lymphotropic virus type 1 (HTLV-1)-transformed cells carry p53 mutations. Nevertheless, the p53 protein in HTLV-1-transformed cells is functionally inactive. We have previously demonstrated that the HTLV-1 Tax protein can inhibit p53 trans-activation function. Tax does not accomplish this by directly binding to p53, but rather by a unique mechanism that includes constitutive phosphorylation of p53 at Ser-15 and Ser-392. Analysis of Tax mutants in lymphocytes demonstrates that Tax-induced p53 inhibition correlates with the ability of Tax to activate NF-kappaB, but not p300 binding or CREB trans-activation. Consistent with these results, expression of the I-kappaBalpha(S32,36A) mutant that blocks NF-kappaB activation blocks Tax-mediated p53 inhibition. We further demonstrate the importance of Tax activation of NF-kappaB in p53 inhibition, using p65 knockout (KO) mouse embryo fibroblasts (MEFs). In the absence of p65 Tax could not inhibit p53. Tax does activate IKKbeta in the p65 KO MEFs, indicating that prenuclear events of NF-kappaB activation are not sufficient for Tax-mediated p53 inhibition, but rather NF-kappaB transcriptional activation is critical. Importantly, using phosphospecific antibodies, we demonstrate that phosphorylation of p53 at Ser-15 and Ser-392 correlates with Tax-mediated inhibition. In addition, mutation of p53 at Ser-15 and Ser-392 to alanines renders p53 resistant to Tax inhibition. This report reviews p53 inhibition by Tax and presents our current model.
Insights
The HTLV-1 Tax protein inactivates the tumor suppressor p53 in cancer cells, not by direct binding, but by inducing specific phosphorylation events linked to NF-kappaB activation. This mechanism highlights a novel pathway for p53 dysfunction in HTLV-1-associated cancers.
Area of Science:
- Molecular Biology
- Virology
- Cancer Research
Background:
- The p53 protein is a critical tumor suppressor that regulates cell cycle arrest and apoptosis in response to genotoxic stress.
- While p53 mutations are common in many cancers, HTLV-1-transformed cells often harbor wild-type but functionally inactive p53.
- The HTLV-1 Tax protein is known to interfere with cellular processes, including p53 function.
Purpose of the Study:
- To elucidate the mechanism by which the HTLV-1 Tax protein inhibits p53 activity in transformed cells.
- To investigate the role of specific p53 phosphorylation sites and NF-kappaB signaling in Tax-mediated p53 inhibition.
Main Methods:
- Analysis of Tax mutants in lymphocytes and mouse embryo fibroblasts (MEFs).
- Utilized phosphospecific antibodies to detect p53 phosphorylation at Ser-15 and Ser-392.
- Employed p65 knockout (KO) MEFs to assess the necessity of NF-kappaB activation.
- Created p53 mutants with alanine substitutions at Ser-15 and Ser-392.
Main Results:
- Tax inhibits p53 trans-activation function through constitutive phosphorylation of p53 at Ser-15 and Ser-392.
- Tax-induced p53 inhibition correlates with NF-kappaB activation, but not p300 binding or CREB trans-activation.
- Blocking NF-kappaB activation prevents Tax-mediated p53 inhibition, and p65 is essential for this process.
- Phosphorylation of p53 at Ser-15 and Ser-392 by Tax is critical for p53 inhibition, as alanine mutants are resistant.
Conclusions:
- The HTLV-1 Tax protein inhibits p53 function via a mechanism dependent on NF-kappaB transcriptional activation.
- Constitutive phosphorylation of p53 at Ser-15 and Ser-392 by Tax is a key event in this inhibitory pathway.
- Understanding this mechanism provides insights into viral oncogenesis and potential therapeutic targets in HTLV-1-associated malignancies.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

